HR 4812 · 108th Congress · Health

Stem Cell Discovery Through Diversity Act

Introduced 2004-07-12· Sponsored by Rep. Deutsch, Peter [D-FL-20]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2004-07-19)

Plain Language Summary

[AI summary unavailable — showing source text] Stem Cell Discovery Through Diversity Act - Requires the Director of the National Institutes of Health (NIH), acting through the national research institutes, to conduct and support research that uses human embryonic stem cells in accordance with the final guidelines issued by NIH and published in the Federal Register on August 25, 2000, including: (1) the requirements that stem cells used in research be derived from human embryos that were created in vitro for fertility treatments and were in excess of the clinical needs of the individual seeking such treatment and that such individuals voluntarily donated such embryos with informed consent; and (2) the prohibition against the use of Federal funds to derive such cells from the embryos. Provides that restrictions on such research established by the Department of Health and Human Services pursuant to policies announced by the President on August 9, 2001, have no legal effect after enactment of this Act. Prohibits additional Federal administrative policies on such research from being established or applied. Requires the Director to ensure that such research program include a significant number of donations from individuals who are me…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (3)

3 Democrats